Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution episode artwork

EPISODE · Jul 10, 2026 · 1H 10M

Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

from DeviceTalks Weekly · host DeviceTalks Podcast Network

In this episode of DeviceTalks Weekly, Host Tom explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. The conversation goes well beyond robotics. Fonseca explains why XCATH hires for humility as much as talent, how a culture of relentless experimentation and "carefrontation" fuels innovation, and why great MedTech companies are built by teams, not lone geniuses.  You'll also hear the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday."  Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.  MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech.  ***  Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.  Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes(00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical(00:15:58) - Medtronic’s chief sustainability officer is departing(00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences(00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system

Episode metadata supplied by the publisher feed · Published Jul 10, 2026

Embed this episode

Ready to play

Ep 296 - XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution

0:00 1:10:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of DeviceTalks Weekly?

This episode is 1 hour and 10 minutes long.

When was this DeviceTalks Weekly episode published?

This episode was published on July 10, 2026.

Can I download this DeviceTalks Weekly episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!